Skip to Content Skip to Search


Haleon CMD to demerger archive

We demerged our world leading consumer healthcare business, Haleon, on 18 July 2022.

Scroll to explore

Consumer Healthcare Capital Markets Day

Haleon CEO-Designate, Brian McNamara, and other members of the Designate Executive Leadership team hosted a virtual Capital Markets Day on 28 February 2022. The programme outlined the strategy for Haleon to deliver sustainable, above-market growth and strong value creation.

Scroll down access the presentations, transcripts, press release and other supplementary information.

Our speakers

  • Brian McNamara

    Chief Executive Officer

  • Tobias Hestler

    Tobias Hestler

    Chief Financial Officer

  • Tamara Rogers

    Chief Marketing Officer

  • Franck Riot

    Head of R&D

  • Teri Lyng

    Head of Sustainability

  • Lisa Paley

    Head of U.S. & North America

  • Filippo Lanzi

    Head of EMEA & LatAm

  • Keith Choy

    Head of Asia Pacific



Sonya Ghobrial, Consumer Healthcare Head of Investor Relations


Delivering shareholder value
Emma Walmsley, Chief Executive Officer, GSK


Haleon: A global consumer healthcare leader delivering sustainable above market growth and attractive returns
Brian McNamara, Chief Executive Officer Designate, Haleon


Competitive capabilities to outperform in the market
Tamara Rogers, CMO & Franck Riot Head of Research & Development


Delivering attractive growth across the regions
Lisa Paley, Head of US & North America
Keith Choy, Head of Asia Pac
Filippo Lanzi, Head of EMEA & Latin America


Running a responsible business, integral to all we do
Teri Lyng, Head of Sustainability


Committed to delivering attractive & sustainable growth, maximizing shareholder value
Tobias Hestler, Chief Financial Officer Designate, Haleon


Bringing it all together
Brian McNamara, Chief Executive Officer Designate, Haleon

Download agenda - PDF - 66kb

Back to top